27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite the known association of diabetes mellitus with cardiovascular events, there are few contemporary data on the long-term outcomes from international cohorts of patients with diabetes mellitus. We sought to describe cardiovascular outcomes at 4 years and to identify predictors of these events in patients with diabetes mellitus.

          Related collections

          Author and article information

          Journal
          Circulation
          Circulation
          1524-4539
          0009-7322
          Sep 8 2015
          : 132
          : 10
          Affiliations
          [1 ] From TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (M.A.C., J.K., K.I., D.L.B.); French Alliance for Cardiovascular Clinical Trials, Département Hospitalo-Universitaire, Fibrosis, Inflammation, Remodeling, Université Paris-Diderot, Sorbonne Paris-Cité, Laboratory of Vascular Translational Science, INSERM U-1148, Hôpital Bichat, Hopitaux Universitaires Paris-Nord Val de Seine, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S.); National Heart Lung Institute, Imperial College, Royal Brompton Hospital, London, UK (P.G.S.); University of North Carolina, Chapel Hill (S.C.S.); University of Michigan, Ann Arbor (K.E.); Duke Clinical Research Institute, Durham, NC (E.M.O.); Tokai University, Kanagawa, Japan (S.G.); and Emory University and the Atlanta VA Medical Center, Atlanta, GA (P.W.F.W.).
          [2 ] From TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (M.A.C., J.K., K.I., D.L.B.); French Alliance for Cardiovascular Clinical Trials, Département Hospitalo-Universitaire, Fibrosis, Inflammation, Remodeling, Université Paris-Diderot, Sorbonne Paris-Cité, Laboratory of Vascular Translational Science, INSERM U-1148, Hôpital Bichat, Hopitaux Universitaires Paris-Nord Val de Seine, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S.); National Heart Lung Institute, Imperial College, Royal Brompton Hospital, London, UK (P.G.S.); University of North Carolina, Chapel Hill (S.C.S.); University of Michigan, Ann Arbor (K.E.); Duke Clinical Research Institute, Durham, NC (E.M.O.); Tokai University, Kanagawa, Japan (S.G.); and Emory University and the Atlanta VA Medical Center, Atlanta, GA (P.W.F.W.). DLBHATTMD@post.harvard.edu.
          Article
          CIRCULATIONAHA.114.014796
          10.1161/CIRCULATIONAHA.114.014796
          26152709
          3e1d8f05-02af-45bc-81ef-022ec8421ba2
          © 2015 American Heart Association, Inc.
          History

          coronary artery disease,diabetes mellitus,heart failure,registries

          Comments

          Comment on this article